🇺🇸 FDA
Patent

US 11478422

Film formulations containing dexmedetomidine and methods of producing them

granted A61KA61K31/4174A61K47/10

Quick answer

US patent 11478422 (Film formulations containing dexmedetomidine and methods of producing them) held by BioXcel Therapeutics, Inc. expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioXcel Therapeutics, Inc.
Grant date
Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/4174, A61K47/10, A61K47/34, A61K47/38